MULTISOURCE (GENERIC) PHARMACEUTICAL PRODUCTS: …
Working document QAS/14.583/Rev.1 page 3 43 BACKGROUND 44 Over the course of time and especially in view of the implementation of the existing 45 guidelines 1 the users have indicated that there was a need to review and update certain 46 requirements.
Download MULTISOURCE (GENERIC) PHARMACEUTICAL PRODUCTS: …
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
fDA Guidance for Industry Dissolution Testing of Immediate ...
www.dissolutiontech.comFDA Immediate Release Guidance ... continued BIDPHARMACEUTICS CLASSIFICATION SYSTEM Based on drug solubility and permeability, thc following
Dissolution Method Development for Immediate Release …
www.dissolutiontech.com12 Dissolution Technologies | AUGUST 2005 Dissolution Method Development for Immediate Release Solid Oral Dosage Forms “Quick Start Guidelines for Early Phase Development Compounds”
European Medicines Agency
www.ema.europa.euEuropean Medicines Agency 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tel. (44-20) 74 18 85 75 Fax (44-20) 75 23 70 40 E-mail: mail@emea.eu.int http://www ...
ORIGINAL ARTICLE FORMULATION AND IN VITRO RELEASE …
www.revistafarmacia.roFARMACIA, 2015, Vol. 63, 1 111 ORIGINAL ARTICLE FORMULATION AND IN VITRO RELEASE TESTING OF RECTAL SUPPOSITORIES CONTAINING NIMESULIDE ANCA CECILIA NICOARĂ1, RADU GEORGE CAZACINCU2*, DUMITRU LUPULEASA1, DALIA SIMONA MIRON3, FLAVIAN ȘTEFAN RĂDULESCU4 1University of Medicine and Pharmacy “Carol Davila” Bucharest, Faculty of …
In Vitro Dissolution Testing for Solid Oral Dosage Forms
www.particlesciences.comthe USP recommended ionic strength.5 For APIs that exhibit low solubilities in aqueous me-dia throughout the pH range, the addition of surfactants is recom-mended.
Related search queries
FDA Guidance for Industry Dissolution Testing of Immediate, Immediate Release, Dissolution Method Development for Immediate Release, Dissolution, Dissolution Method Development for Immediate Release Solid, European Medicines Agency, RELEASE, RELEASE TESTING OF RECTAL SUPPOSITORIES CONTAINING NIMESULIDE, Dissolution Testing, Solid